검색
Quanterix Corp
QTRX관심 목록에 추가
4.330USD
-0.010-0.23%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
203.77M시가총액
손실P/E TTM
자세한 내용은 Quanterix Corp 회사
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corp 정보
종목 코드 QTRX
회사 이름Quanterix Corp
상장일Dec 07, 2017
CEOToloue (Masoud)
직원 수471
유형Ordinary Share
회계 연도 종료Dec 07
주소900 Middlesex Turnpike
도시BILLERICA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01821
전화16173019400
웹사이트https://www.quanterix.com/
종목 코드 QTRX
상장일Dec 07, 2017
CEOToloue (Masoud)
Quanterix Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
154.13K
+8.83%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
12.35K
-155.84%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
6.97K
-335.42%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
154.13K
+8.83%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
12.35K
-155.84%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
자주 묻는 질문
Quanterix Corp의 상위 5대 주주는 누구인가요?
Quanterix Corp의 상위 5대 주주는 다음과 같습니다: Dr. Masoud Toloue, Ph.D.
Quanterix Corp(QTRX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Quanterix Corp의 주식을 보유한 기관은 총 371곳이며, 이들이 보유한 주식의 총 가치는 약 42.63M로 전체 발행 주식의 90.49%를 차지합니다. 이는 2025Q4 대비 -4982326.00 증가한 수치입니다.
Quanterix Corp의 최대 수익원은 무엇인가요?
2026Q1 기준, Quanterix Corp의 Product revenue 부문이 가장 높은 매출을 기록했으며, 금액은 92.94M로 전체 매출의 67.03%를 차지했습니다.